Regeneron Pharmaceuticals Inc

Healthcare
$788.18
+10.18(1.31%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Open PricePrev. CloseVolumeAvg. Volume
$777.00$778.001,027,335846,110

Fundamentals

Market Cap$86.59B
P/B Ratio3
P/E Ratio18.6
Enterprise Value$87.28B
Div. Yield0.00%
Book Value234.28
EPS(TTM)9.48
ROENA
Understand Fundamentals

About the Company

An American biotechnology company, Regeneron Pharmaceuticals has its headquarters in Westchester County, New York. The place is located around 25 miles north of Midtown Manhattan. Founded in 1988, the company is mostly focused on neurotrophic factors and regenerative capabilities associated with them, leading to the adoption of this company's name. The company has developed various products including a VEGF inhibitor, aflibercept, an interleukin-1 blocker and rilonacept. Bloomberg would go on to announce that Sanofi and Regeneron were developing a new drug by March 2012. This drug would help reduce cholesterol up to 72% more than many of its competitors. The company also produces different kinds of drugs, such as Arcalyst meant for specific, rare autoinflammatory conditions. It was approved by the FDA in 2008. Eylea, used to treat common causes of blindness in the elderly, was approved by the FDA in November 2011. Zaltrap, another drug by the company, is for metastatic colorectal cancer and was approved by the FDA in August 2012. The company also produced other drugs like Praluent for clinical atherosclerotic cardiovascular disease, requiring additional lowering of low-density lipoprotein (LDL) cholesterol. Dupixent is a drug developed by this company to treat adolescent and adult atopic dermatitis. Kevzara, another notable product of this company, is a solution for subcutaneous injection and ZALTRAP injection for Intravenous Infusion. It has nearly 16 products that are in the process of clinical development. This company ranked at 151 in the World's Best Employers list 2020 and 62 in Just Companies' list in 2021. It also ranked at 646 in the Global 2000 list 2020 and 275 in Best Employers for Diversity list in 2020. This company also ranked at 61 in the list of America's Best Midsize Employers in 2019 and at 145 in the Best Employers for Women in 2018. It has a workforce of 8100 employees and has offices in three countries, including the United States, Ireland and the United Kingdom. The company got the 16th rank in the list of World's Most Innovative Companies in 2018. Regeneron Pharmaceuticals shares trade on the NASDAQ stock exchange under the ticker symbol "REGN.";
OrganisationRegeneron Pharmaceuticals Inc
IndustryBiotechnology
HeadQuartersTarrytown, NY

Company Financials

*All values are in Million $
No Graph Data To Display
Quarterly
Yearly

Similar Stocks

COMPANYMARKET PRICECLOSE PRICEMARKET CAP
Invest the way you want
Join millions of Indians who trust and love Groww
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.8
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ